Trial intelligence / Profile preview

Linaclotide for constipation in patients with mental illness

ChiCTR2200063143Phase 4Not yet recruiting

Sponsor
984 Hospitail of Joint Logistic Support Force
Start
Sep 2022
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised trial of linaclotide in constipation (2 arms), sponsored by 984 Hospitail of Joint Logistic Support Force. Primary endpoint: Frequency of spontaneous defecation per week after treatment. Planned start Sep 2022; status: not yet recruiting.

02

Drugs

linaclotide
03

Conditions

constipation

Beyond the preview

Go deeper on ChiCTR2200063143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200063143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call